All In Biotech

Drug Trial Radar · NCT06388889

Phase III Long-Term Extension Study With Dexpramipexole

An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic Asthma

Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

509

Actual

Start

Jun 12, 2024

Primary completion

Dec 8, 2025

Study completion Dec 8, 2025

Sponsor

Lead sponsor
Areteia TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial\] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥18 years, on Global Initiative for Asthma (GINA) 2021 \[GINA, 2021\] Step 4 or 5 therapy and who completed either of the Phase III studies EXHALE-2 or EXHALE-3.

Conditions

  • Eosinophilic Asthma

Interventions

  • Dexpramipexole DihydrochlorideDrug

    Oral administration of dexpramipexole tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Percentage of Participants with a Treatment Emergent Adverse EventTime frame: 52 weeks
  2. Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Clinical Laboratory EvaluationsTime frame: 52 weeks
  3. Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Vital Signs and Body WeightTime frame: 52 weeks
  4. Number and Percentage of Participants with Potentially Significant Postbaseline Changes in Electrocardiogram ParametersTime frame: 52 weeks

Locations

103 sites in 15 countries. Site status is shown where the registry gives one.

  • Research Site 20001-374

    Bakersfield, California

  • Research Site 20001-376

    Northridge, California

  • Research Site 20001-029

    Coral Gables, Florida

  • Research Site 20001-014

    Greenacres City, Florida

  • Research Site 30001-291

    Jacksonville, Florida

  • Research Site 20001-066

    Miami, Florida

  • Research Site 20001-001

    Miami, Florida

  • Research Site 20001-311

    Miami, Florida

  • Research Site 20001-026

    Miami, Florida

  • Research Site 30001-082

    Miami, Florida

  • Research Site 20001-024

    Miami, Florida

  • Research Site 20054-024

    Miami, Florida

  • Research Site 30001-429

    Plantation, Florida

  • Research Site 30001-429

    Plantation, Florida

  • Research Site 20001-004

    Tampa, Florida

  • Research Site 20001-036

    Elwood, Indiana

  • Research Site 20001-044

    Evansville, Indiana

  • Research Site 20001-006

    Flint, Michigan

  • Research Site 20001-046

    St Louis, Missouri

  • Research Site 20001-355

    Toms River, New Jersey

  • Research Site 20001-047

    Hawthorne, New York

  • Research Site 20001-063

    Toledo, Ohio

  • Research Site 30001-297

    Pearland, Texas

  • Research Site 30054-044

    Buenos Aires, Argentina

  • Research Site 20054-017

    Buenos Aires, Argentina

  • Research Site 20054-015

    Buenos Aires, Argentina

  • Research Site 20054-022

    Buenos Aires, Argentina

  • Research Site 20054-024

    Buenos Aires, Argentina

  • Research Site 20054-008

    Buenos Aires, Argentina

  • Research Site 20054-005

    Córdoba, Argentina

  • Research Site 30054-047

    Mendoza, Argentina

  • Research Site 20054-019

    Mendoza, Argentina

  • Research Site 20054-016

    Mendoza, Argentina

  • Research Site 20054-010

    Mendoza, Argentina

  • Research Site 20054-002

    San Miguel de Tucumán, Argentina

  • Research Site 20054-020

    San Miguel de Tucumán, Argentina

  • Research Site 20054-013

    Santa Fe, Argentina

  • Research Site 20055-007

    Blumenau, Brazil

  • Research Site 20055-004

    Porto Alegre, Brazil

  • Research Site 20055-010

    Porto Alegre, Brazil

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.